Showing results (861-870 of 1,598) with videos related to
Sort By:
Pageof 160
Endocrinology|January 14, 1999
AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activationF Aslam, L McCabe, B Frenkel, et al.The Journal of Biological Chemistry|May 8, 2013
Adenylyl cyclase anchoring by a kinase anchor protein AKAP5 (AKAP79/150) is important for postsynaptic β-adrenergic signalingMingxu Zhang, Tommaso Patriarchi, Ivar S Stein, et al.Experimental Cell Research|March 20, 2002
1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoterHicham Drissi, Arlyssa Pouliot, Christian Koolloos, et al.Journal of Cellular Biochemistry|June 1, 1994
Transcriptionally active nuclei isolated from intact bone reflect modified levels of gene expression in skeletal development and pathologyV Shalhoub, R Bortell, M E Jackson, et al.Journal of Cellular Physiology|August 1, 1994
Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitroL M Barone, M A Aronow, M S Tassinari, et al.Endocrinology|December 30, 1999
Developmental regulation of thyrotropin receptor gene expression in the fetal and neonatal rat thyroid: relation to thyroid morphology and to thyroid-specific gene expressionR S Brown, V Shalhoub, S Coulter, et al.Plos One|November 28, 2017
Genome-wide DNase hypersensitivity, and occupancy of RUNX2 and CTCF reveal a highly dynamic gene regulome during MC3T3 pre-osteoblast differentiationPhillip W L Tai, Hai Wu, André J van Wijnen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sitesSayyed K Zaidi, Andrew J Sullivan, Andre J van Wijnen, et al.Diseases of the Colon and Rectum|October 13, 2001
HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patientsJ H Kim, B Sarani, B A Orkin, et al.Antimicrobial Agents and Chemotherapy|January 18, 2002
Pharmacodynamics of abacavir in an in vitro hollow-fiber model systemG L Drusano, P A Bilello, W T Symonds, et al.Pageof 160